IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Protagonist Therapeutics Inc

Q2 2019 vs Q3 2019

Comparing institutional holders between quarters

Quarters

Q3 2019Q2 2019Q1 2019Q4 2018Q3 2018
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile
Perceptive Advisors LLC
UNCHANGED
Shares2,071,297 from 2,071,297
Change0 (0%)
Value$24.9K (-$207)
Filed 2019-11-14
Status
Perceptive Advisors LLC
UNCHANGED2,071,2972,071,29700%$25.1K$24.9K-$2072019-11-14
Showing 1 of 1 institutions